Calcification of the breast is often an outward manifestation of underlying molecular changes that drive carcinogenesis. Up to 50% of all non-palpable breast tumors and 90% of ductal carcinoma in situ present with radiographically dense mineralization in mammographic scans. However, surprisingly little is known about the molecular pathways that lead to microcalcifications in the breast. Here, we report on a rapid and quantitative in vitro assay to monitor microcalcifications in breast cancer cell lines, 
exocytosis of matrix vesicles loaded with calcium phosphate, exosome release, and direct secretion of non-membrane bound apatite crystals into the extracellular matrix. Common to many of these mechanisms is the role of transporters and enzymes that fuel the accumulation of mineral ions, including Ca 2+ and Pi. The phosphatase PHOSPHO1
generates phosphates by hydrolysis of phosphocholine and phosphoethanolamine, derived from membrane phospholipids by phospholipase C. 12 Alkaline phosphatase (AP) and nucleotide pyrophosphatase phosphodiesterase I (NPP1) have also been implicated in generating inorganic phosphates from organic precursors that are delivered to calcification sites by the Type III Na/Pi co-transporter found on cell and vesicle membranes. 12 Although the obvious importance of Ca 2+ transporters in formation of breast microcalcifications has been recognized, 9 evidence supporting their molecular identity and function is surprisingly lacking.
A few Ca 2+ channels, including annexins 2, 13, 14 and TRP isoforms 9, 15 have been associated with vascular or breast calcifications, respectively. However, passive, downhill Ca 2+ flux by ion channels is unlikely to play a primary role in the accumulation of Ca 2+ at microcalcification sites. Therefore, we considered the role of ATP-driven Ca 2+ pumps that localize to the Golgi and post-Golgi vesicles, belonging to the subgroup of Secretory Pathway Ca 2+ -ATPases. 16, 17 In mammary tissue, there are two SPCA pump isoforms that mediate high affinity transport of Ca 2+ and Mn 2+ from the cytoplasm to the lumen. [18] [19] [20] The delivery of these cations to secretory compartments is critical for posttranslational protein processing, glycosylation, sorting, and quality control. 21, 22 In the lactating breast, expression of SPCA isoforms is dramatically elevated to facilitate transcytosis of Ca 2+ from the blood to the lumen of the mammary gland where it accumulates in milk at concentrations of 40-80 mM. [23] [24] [25] Of particular relevance, an unconventional interaction of SPCA2 with the Ca 2+ influx channel Orai1, evidenced by co-induction by lactogenic hormones, and coimmunoprecipitation, was required for Ca 2+ transport in threedimensional mammosphere cultures. 23, 26 Gene dysregulation of both SPCA1 (ATP2C1) and SPCA2 (ATP2C2) has been linked to breast cancers 18 : SPCA1 is important for promoting processing of the insulinlike growth factor 1 receptor (IGF-1R), and SPCA2 promotes tumor growth by increasing Ca 2+ entry through activation of the Orai1 calcium channel. 26, 27 Thus, we reasoned that the SPCA pumps are likely to be important players in formation of breast microcalcifications.
A major impediment to the identification of novel genes and cellular pathways of microcalcification is a lack of a convenient and quantifiable assay of calcium deposition using well-characterized human breast tumor cell lines. A cocktail of extrinsic factors that are important for osteogenic differentiation of bone marrow derived mesenchymal stem cells is typically used to elicit mineralization in vitro. 28, 29 
| Gene knockdown and overexpression
shRNA knockdown constructs and were packaged into the pLK0.1 lentiviral system whereas SPCA2 and SPCA2 D379N rescue constructs were packaged into the FUGW lentiviral backbones. These lentiviruses were produced with pCMV-Δ8.9 and PMDG using a 9 
| Image quantification and statistical analysis
All raw images were converted to a digitized 8-bit binary image in
ImageJ by adjusting the threshold to correct for the background (lower limit: 0, upper limit: 70). The Analyze Particle tool of ImageJ software was utilized to outline each microcalcification and generate counts and areas of outlined particles. Histograms and bar graphs were made using
GraphPad Prism and statistical analysis using an unpaired Student's t-test was applied to the quantifications where applicable.
| Bioinformatics analysis
The Cancer Genome Atlas (TCGA) invasive breast carcinoma project datasets were accessed through the cBioPortal (http://www.
cbioportal.org/). 31 The microarray data set GSE21422 was analyzed to compare SPCA1 (ATP2C1) and SPCA2 (ATP2C2) gene expression in control healthy breast, ductal carcinoma in situ (DCIS), and invasive ductal carcinoma (IDC) (n = 19). 32 3 | RESULTS Next, we assessed whether the calcium deposits observed within this short time frame were related to previously reported microcalcifications. A well known physiological regulator of mineralization is bone morphogenetic protein-2 (BMP2), a secreted protein of the transforming growth factor-β (TGF-β) family that has been implicated as a driver of luminal-type breast cancers. 37 Binding of BMP2 to the serine/threonine kinase receptor BMP receptor 1 (BMPR1) activates the downstream phosphorylation pathway of the Smad proteins to induce expression of bone matrix proteins. BMP2 has been shown to induce mineralization of breast tumors in a rodent model in vivo, 38, 39 and to enhance microcalcifications in mouse mammary 4T1 cells in vitro. 33 Here, we show that addition of BMP2 results in dosedependent enhancement of in vitro microcalcifications in MCF7
| Human breast carcinoma cells form microcalcifications in vitro
cancer cells (Figure 2A-E) . Due to the accelerated time course, supraphysiological levels of BMP2 were most effective, which is not surprising given that calcifications occur over the period of months and 90% of DCIS present with breast calcifications which may be linear or granular, depending on grade. 40 Whereas basal cancers are not associated with calcification, 41 luminal A/B types have amorphous deposits with poorly circumscribed margins. 42 Mammographic microcalcifications are most likely to be found in HER2-positive breast cancers, where they are large and infiltrating. [42] [43] [44] As a first step toward evaluating the role of secretory pathway Ca 2+ pumps in development of breast microcalcifications, we assessed the expression of SPCA1 and SPCA2 transcripts in mammary cancer subtypes. The housekeeping (ie, ubiquitously expressed) SPCA1 isoform was modestly, albeit significantly, up regulated in mammary ductal carcinoma in situ (DCIS; 1.59-fold higher, P = 0.0083; Student's t-test), but not in invasive ductal carcinoma (IDC; P = 0.24), relative to healthy control breast samples ( Figure 3A) . Notably, SPCA2 transcript was significantly up regulated both DCIS (6.18-fold higher, P = 0.02; Student's t-test) and in IDC (6.12-fold higher, P = 0.03; Student's t-test) ( Figure 3B ). 32 Next, we analyzed sub-type specific expression of SPCA isoforms in 508 breast cancer samples from the TCGA dataset. Whereas high SPCA1 levels were associated with basal subtype of cancer ( Figure 3C ), SPCA2 was significantly elevated in Luminal A/B and HER2+ subtypes (P < 0.001, Figure 3D ) that are strongly associated with breast microcalcifications. Whereas both SPCA isoforms may contribute to calcifications observed in DCIS, high expression of SPCA2 appears to be more predictive of breast microcalcifications. These results are intriguing because the two SPCA isoforms share 64% sequence identity and similar ion selectivity and transport properties, 18 but show distinct and subtype-specific associations in breast cancer.
| SPCA isoforms are induced in osteogenic conditions
Genes involved in the formation of calcifications may show transcriptional changes in response to osteogenic conditions. We observed robust induction of both SPCA isoforms in OC supplemented media, in MCF7 and Hs578T cells. Concomitantly, alkaline phosphatase (ALP) and bone sialoprotein (BSP2) were also induced, as previously reported 7 ( Figure 4A,B) . Given the paucity of information on transcriptional control of SPCA genes, it was of interest to determine whether induction was mediated by any particular component of OC. We found that addition of individual OC components to growth media failed to elicit increases in SPCA transcripts in MCF7 (not shown), as did combinations of OC components ( Figure 4C ). Similarly, we failed to observe increases in
FIGURE 4
Osteomimetic induction of SPCA pumps in breast cancer mineralization. (A) Hs578T cells were grown to confluency and cultured for 5 days with or without OC supplemented media. RNA was collected from biological triplicates and cDNA was synthesized. qPCR was performed for SPCA1 (**P < 0.01, Student's t-test, n = 3), SPCA2 (**P < 0.01, Student's t-test, n = 3), ALP (***P < 0.0001, Student's t-test, n = 3), and BSP2 (*P < 0.05, Student's t-test, n = 3). (B) MCF7 cells were grown and treated as in (A). qPCR was performed for SPCA (**P < 0.01, Student's t-test, n = 3), SPCA2 (**P < 0.01, Student's t-test, n = 3), ALP (*P < 0.05, Student's t-test, n = 3), and BSP2 (***P < 0.001, Student's t-test, n = 3). (C) MCF7 cells were grown to confluency and cultured for 5 days in various media supplemented with two or more components of OC as indicated: dexamethasone (Dex), ascorbic acid (AA), and inorganic phosphate (P). RNA was collected from biological triplicates and cDNA was synthesized. qPCR was performed for SPCA1 (**P < 0.01, Student's t-test, n = 3) and SPCA2 (**P < 0.01, Student's t-test, n = 3)
BSP2 transcript in the absence of complete OC (not shown). Thus, the addition of ascorbic acid, phosphate, and dexamethasone is necessary and sufficient for eliciting SPCA transcript increases during microcalcification formation in MCF7 tumor cells (Figure 4 ).
| SPCA1 and SPCA2 promote microcalcification mineralization in vitro
We reasoned that SPCA overexpression should enhance Ca 2+ loading of the Golgi stores, leading to increased Ca 2+ secretion and promotion of extracellular calcification. To directly test this hypothesis, we transiently overexpressed SPCA1 in MCF7 cells ( Figure 5A -C), which have relatively low endogenous expression of this isoform. 31 Following culture in OC supplemented media for 5 days, we observed stronger Alizarin Red staining ( Figure 5A ) and significant increase in number of microcalcifications ( Figure 5B ) compared with vectortransformed control. Whereas, endogenous SPCA2 levels are high in MCF7 cells, expression of this isoform is relatively low in Hs578T cells. 31 We show that ectopic expression of SPCA2 in Hs578T cells also significantly enhanced in vitro microcalcifications in Hs578T
( Figure 5D-F) . Previously, SPCA2 was shown to exhibit ATPasedependent role in sequestering Ca 2+ into Golgi stores, as well as an unconventional pump-independent role in mediating tumor cell proliferation by eliciting Ca 2+ influx through plasma membrane ion channels. 26 To distinguish between these two roles, we evaluated the effect of a catalytically inactive SPCA2 mutant, D379N, previously confirmed by qPCR (I); **P < 0.01 and ***P < 0.001, Student's t-test, n = 3 for each condition. MCF7 cells treated with shSPCA2 were transfected with wild type or D379N silencing-resistant SPCA2 constructs. Transcripts were monitored by qPCR (J) and microcalcifications were quantified as described above (K); **P < 0.01, Student's t-test
shown to lack ATPase and Ca 2+ pumping activity while retaining normal expression levels and localization. 26 Unlike the wild type control, mutant 
| DISCUSSION
Calcification of breast carcinomas is a well-recognized histological and radiographic feature that has been associated with poorer survival in breast cancer patients. 1 Although detailed descriptive information is [45] [46] [47] Expression of SPCA2 is high in breast, prostate, and lung tissues, whereas SPCA1 has ubiquitous tissue expression. 20 Microcalcifications are significantly more prevalent in patients with amplification of the proto-oncogene HER2 (also known as c-erbB2) breast tumors, compared to tumors without amplification of HER2. 43, 53, 54 It is noteworthy that SPCA2 up regulation is most prominent in ductal carcinomas, and more specifically in HER2 positive breast tumors. 18, 32 We have shown that high levels of SPCA2 expression in mammary cancers correlate with tumor proliferation and poor survival prognosis. 26 These correlative observations, taken together with in vitro evidence from this study strongly suggest that SPCA pumps are a driver of microcalcifications in breast tumors and may offer clinical and physiological insight into the formation of microcalcifications and the tumor microenvironment.
